Screener
aTyr Pharma ATYR Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
FAQ
- What is aTyr Pharma's shares (diluted)?
- aTyr Pharma (ATYR) reported shares (diluted) of 98.1M in Q2 2026.
- How has aTyr Pharma's shares (diluted) changed year-over-year?
- aTyr Pharma's shares (diluted) increased by 8.8% year-over-year, from 90.1M to 98.1M.
- What is the long-term trend for aTyr Pharma's shares (diluted)?
- Over 4 years (2021 to 2025), aTyr Pharma's shares (diluted) has grown at a 52.7% compound annual growth rate (CAGR), from 67.5M to 366.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about aTyr Pharma's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude